Elocon and Acute myocardial infarction - a phase IV clinical study of FDA data

Summary:

Acute myocardial infarction is reported as a side effect among people who take Elocon (mometasone furoate), especially for people who are male, 60+ old, also take Vioxx, and have Fluid retention.

The phase IV clinical study analyzes which people have Acute myocardial infarction when taking Elocon. It is created by eHealthMe based on reports of 1,989 people who have side effects when taking Elocon from the FDA, and is updated regularly.

What is Elocon?

Elocon has active ingredients of mometasone furoate. It is often used in eczema. eHealthMe is studying from 2,019 Elocon users. Check the latest studies of Elocon.

What is Acute myocardial infarction?

Acute myocardial infarction (acute heart attack) is found to be associated with 1,462 drugs and 1,617 conditions by eHealthMe. Check the latest studies of Acute myocardial infarction.

On Jul, 03, 2026

1,989 people reported to have side effects when taking Elocon.
Among them, 19 people (0.96%) have Acute myocardial infarction.

Could Elocon cause Acute myocardial infarction?

Among these 19 people:

What is the gender of people who have Acute myocardial infarction when taking Elocon? *

female: 42.11 %
male: 57.89 %

What is the age of people who have Acute myocardial infarction when taking Elocon? *

What are other drugs people take besides Elocon? *

What are other side effects people have besides Acute myocardial infarction? *

High Blood Cholesterol: 6 people, 31.58%
Atrioventricular Block Complete (heart block complete): 6 people, 31.58%
Dizziness: 6 people, 31.58%
Stable Angina (a constant chest pain): 6 people, 31.58%
Weight Decreased: 5 people, 26.32%
Cardiac Arrest: 4 people, 21.05%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 21.05%
Sick Sinus Syndrome (a collection of heart rhythm disorders): 4 people, 21.05%
Mitral Valve Incompetence (inefficient heart valve): 4 people, 21.05%
Stress And Anxiety: 4 people, 21.05%

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 15.79%
Rashes (redness): 3 people, 15.79%
Depression: 3 people, 15.79%
Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 15.79%
Fungal Skin Infection: 2 people, 10.53%
Skin Disorder (skin disease): 2 people, 10.53%
Diabetes: 2 people, 10.53%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 10.53%
Pain: 2 people, 10.53%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Elocon and have Acute myocardial infarction?

- Check whether Acute myocardial infarction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Elocon:

Elocon (2,019 reports)

Browse all side effects of Elocon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acute myocardial infarction:

Acute myocardial infarction (1,462 drugs)

Browse all the conditions that are associated with Acute myocardial infarction:

Acute myocardial infarction (1,617 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate (the active ingredients of Elocon) and Elocon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.